SCHEMBL19676568

SCHEMBL19676568

C=C(c1n[nH]c2ccccc12)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.53
▸ YTHDC1 Q96MU7 1/20 0.53
▸ STAT3 P40763 1/20 0.53
▸ HIF1A Q16665 1/20 0.53
▸ FLT3 P36888 5/20 0.46
▸ CDK2 P24941 2/20 0.46
▸ CCNA2 P20248 1/20 0.46
▸ CCNA1 P78396 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ CTNNB1 P35222 2/20 0.45
▸ WNT3A P56704 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ IDO1 P14902 1/20 0.44
▸ GAA P10253 2/20 0.44
▸ PDPK1 O15530 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ MAP4K1 Q92918 1/20 0.43
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19675209 0.80 KDM4E (0.57) KDM4EYTHDC1STAT3HIF1AFLT3
SCHEMBL18858493 0.79 KDM4E (0.61) KDM4EYTHDC1STAT3HIF1AFLT3
SCHEMBL19675153 0.79 MAP2K4 (0.48) FLT3MAP4K1
SCHEMBL19675476 0.79 KDM4E (0.53) KDM4EYTHDC1STAT3HIF1AFLT3
SCHEMBL25139723 0.77 KDM4E (0.48) KDM4EYTHDC1STAT3HIF1AFLT3
SCHEMBL217086 0.73 KDM4E (0.67) KDM4EYTHDC1STAT3HIF1AFLT3
SCHEMBL12441826 0.73 KDM4E (0.57) KDM4EYTHDC1STAT3HIF1AFLT3
SCHEMBL29781840 0.73 KDM4E (0.67) KDM4EYTHDC1STAT3HIF1AFLT3
SCHEMBL2704442 0.72 SMN1; SMN2 (0.71) KDM4EYTHDC1STAT3HIF1AFLT3
SCHEMBL7668372 0.72 KDM4E (0.66) KDM4EYTHDC1STAT3HIF1AFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252049-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 — — EP disclosed
Send feedback